Ceramides increase mitochondrial permeabilization to trigger mtDNA-dependent inflammation in astrocytes during brain ischemia
Top Cited Papers
- 15 February 2025
- journal article
- Published by Elsevier in Metabolism
- Vol. 166, 156161
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82003979)
This publication has 32 references indexed in Scilit:
- Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatmentJournal of the Formosan Medical Association, 2022
- Mitochondrial quality control mechanisms as molecular targets in diabetic heartMetabolism, 2022
- Plasma ceramides are associated with outcomes in acute ischemic stroke patientsJournal of the Formosan Medical Association, 2022
- Aerobic Glycolysis in the Brain: Warburg and Crabtree Contra PasteurNeurochemical Research, 2020
- Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorderMetabolism, 2019
- CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in ObesityCell, 2019
- Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid ToxicityCell, 2019
- Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver diseaseMetabolism, 2018
- Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker ratsMolecular Metabolism, 2018
- Central Ceramide-Induced Hypothalamic Lipotoxicity and ER Stress Regulate Energy BalanceCell Reports, 2014